{"url_path":"/sec/ints/8-k/2026-08-11/item-2-02","section_key":"item-2-02","section_title":"Item 2.02 Results of Operations and Financial Condition.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-08-11","source_url":"https://www.sec.gov/Archives/edgar/data/1567264/0001567264-26-000061-index.html","accession_number":"0001567264-26-000061","cik":"0001567264","ticker":"INTS","issuer_name":"INTENSITY THERAPEUTICS, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1567264/0001567264-26-000061-index.html","primary_entity_key":"0001567264","primary_entity_name":"INTENSITY THERAPEUTICS, INC."},"word_count":114,"has_tables":true,"body_markdown":"Item 2.02 Results of Operations and Financial Condition.\n\nOn August 11, 2026, Intensity Therapeutics, Inc. (the “Company”) released its financial results for the three and six months ended June 30, 2026. A copy of the Company’s press release is attached as Exhibit 99.1 to this Form 8-K and incorporated herein by reference.\n\nThe information in this report shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, except as shall be expressly set forth by specific reference in such filing."}